1. AB0879 Pharmacokinetics, Safety, and Tolerability of Tofacitinib in Paediatric Patients from Two To Less than Eighteen Years of Age with Juvenile Idiopathic Arthritis. (15th July 2016) Authors: Ruperto, N.; Brunner, H.I.; Hazra, A.; Wang, R.; Mebus, C.; Alvey, C.; Lamba, M.; Krishnaswami, S.; Conte, U.; Wang, M.; Tzaribachev, N.; Foeldvari, I.; Horneff, G.; Kingsbury, D.; Koskova, E.; Smolewska, E.; Vehe, R.K.; Zuber, Z.; Martini, A.; Lovell, D. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0328 Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): 2-year data from tender, a phase 3 clinical trial. (23rd January 2014) Authors: De Benedetti, F.; Brunner, H.; Ruperto, N.; Kenwright, A.; Devlin, C.; Calvo, I.; Cuttica, R.; Ravelli, A.; Schneider, R.; Eleftheriou, D.; Wouters, C.; Xavier, R.; Zemel, L.; Baildam, E.; Burgos-Vargas, R.; Dolezalova, P.; Garay, S.M.; Joos, R.; Grom, A.; Wulffraat, N. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 425 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP0060 Efficacy and Safety of Tocilizumab in Patients with Polyarticular Juvenile Idiopathic Arthritis: Data from a Phase 3 Trial. (23rd January 2014) Authors: De Benedetti, F.; Ruperto, N.; Zuber, Z.; Keane, C.; Harari, O.; Kenwright, A.; Cuttica, R.; Keltsev, V.; Xavier, R.; Calvo, I.; Nikishina, I.; Rubio-Pérez, N.; Alekseeva, E.; Chasnyk, V.; Chavez, J.; Horneff, G.; Opoka-Winiarska, V.; Quartier, P.; Silva, C.; Silverman, E. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. THU0508 Safety and Efficacy of Tocilizumab in Patients with Systemic Juvenile Idiopathic Arthritis: 5-Year Data from Tender, A Phase 3 Clinical Trial. (9th June 2015) Authors: De Benedetti, F.; Ruperto, N.; Brunner, H.; Keane, C.; Wells, C.; Wang, J.; Calvo, I.; Cuttica, R.; Ravelli, A.; Schneider, R.; Eleftheriou, D.; Wouters, C.; Xavier, R.; Zemel, L.; Baildam, E.; Burgos-Vargas, R.; Dolezalova, P.; Garay, S.M.; Joos, R.; Grom, A. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 384 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. THU0537 Selected Factors of Complement Lectin Pathway Factors in Polish Children with Juvenile Idiopathic Arthriti. (9th June 2015) Authors: Zuber, Z.; Kasperkiewicz, K.; Michalski, M.; Eppa, Ł.; Bartłomiejczyk, M.; Świerzko, A.; Mężyk, E.; Noszczyńska, M.; Cedzyński, M. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 394 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗